Skip to content

Physiological dose steroid therapy in sepsis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN36253388
Enrollment
40
Registered
2002-04-15
Start date
1997-05-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis and adrenal insufficiencies Infections and Infestations Sepsis and adrenal insufficiencies

Interventions

Patients enrolled in the study were treated with standard therapy used in the treatment of sepsis and septic shock. This therapy could include administration of antibiotics, fluid replacement, vasoact

Sponsors

Erciyes University (Turkey)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients over 17 years old and diagnosed with sepsis were included in the study consecutively. The diagnosis of sepsis was based on the definition of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Report. The severity of illness was classified according to this definition.

Exclusion criteria

Exclusion criteria: Criteria for exclusion from the study were as follows: 1. Already known pre-existing adrenal disease or adrenalectomy 2. Known malignancies, tuberculosis that might have involved the adrenal gland 3. Administration of steroids within the three months before the admission 4. In addition, patients with burns, hemorrhagic shock or those who had suffered myocardial infarction were not included

Design outcomes

Primary

MeasureTime frame
The primary endpoint of the study was 28-day mortality from all causes.

Secondary

MeasureTime frame
The secondary endpoint consisted of adverse occurrences including possible complications of drug therapy and morbid events such as the progression of initial infection and the development of secondary infection. Secondary infection was defined as the identification of a new site of infection or the emergence of a different organism at the same site, generally requiring a change in antibiotic management.

Countries

Turkey

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 17, 2026